Characterization of the Charcot Foot
Follow-up on Cross-sectional Study of Known Population With Charcot Osteoarthropathy - Metabolic, Physiologic and Pathologic Changes
1 other identifier
observational
21
1 country
1
Brief Summary
The project concerns a type of very debilitating diabetic foot complications called Charcots osteoarthropathy (COA). This disease is characterized by a rapidly progressing destruction of the load bearing joints, primarily in the feet, resulting in loss of structure and remodeling. Untreated this cascade leads to the collapse of the bones, meaning severe pain and walking disability for the patient. Reconstruction is often very difficult or impossible, and furthermore the collapse can lead to chronic foot ulcers and infections, which in the worst case can be fatal. Treatment options are currently limited to early diagnosis and physical offloading (immobilisation), assisted wound healing and surgical intervention. The purpose of this project is to investigate and describe the bone-related factors, which separate COA from other, less acute, diabetic foot changes. The investigators wish to describe the long term consequences of COA - both anatomically, physiologically and biochemically. The investigators will be doing this in a follow-up investigations on a group of COA patients tested 8 years ago. Little is known of the long term changes to the bone structure after acute COA, and the investigators want to visualize to what extend the bone damage is permanent. To do this the investigators will be using DXA-scans, x-ray, blood tests including bone markers, neurophysiological tests and occlusion plethysmography.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2014
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 27, 2014
CompletedStudy Start
First participant enrolled
September 1, 2014
CompletedFirst Posted
Study publicly available on registry
January 12, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2017
CompletedMarch 31, 2020
March 1, 2020
2.3 years
June 27, 2014
March 28, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Disease progression in the previously affected foot
initiation
Secondary Outcomes (4)
Bone mineral density of os. calcaneus
initiation
Peripheral neuropathy in the feet
initiation
Peripheral blood supply
initiation
Altered levels of bone resorption markers
initiation
Other Outcomes (2)
Amputations
initiation
Diabetes regulation
initiation
Study Arms (2)
Charcot foot
Patients with Charcot foot and diabetes mellitus 1 or 2
No charcot foot
patients with diabetes mellitus type 1 or 2
Eligibility Criteria
Follow-up study, population of patients referred with charcot foot 8 years ago. Control population without Charcot foot, taken from the outpatient clinic.
You may qualify if:
- Followed in the previous study
You may not qualify if:
- Unable to attend follow-up
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bispebjerg Hospital
København NV, 2400, Denmark
Biospecimen
Frozen full blood samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rasmus B Jansen, MD
Bispebjerg Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
June 27, 2014
First Posted
January 12, 2015
Study Start
September 1, 2014
Primary Completion
January 1, 2017
Study Completion
July 1, 2017
Last Updated
March 31, 2020
Record last verified: 2020-03